3M India (523395) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
22 May, 2026Executive summary
Achieved 16.8% sales growth in Q4 and 14.5% for the full year compared to prior periods.
All business segments posted double-digit growth for the year, led by Health Care.
EBITDA, PBT, and PAT grew strongly both sequentially and year-over-year.
Board recommended a total dividend of Rs. 506 per share, including a special dividend.
Financial highlights
Q4 FY26 revenue: Rs. 1,399 crore, up 16.8% YoY; full year: Rs. 5,090 crore, up 14.5% YoY.
Q4 EBITDA: Rs. 269 crore (+12.2% YoY); full year EBITDA: Rs. 1,035 crore (+23.2% YoY).
Q4 PAT: Rs. 215 crore (+201.7% YoY); full year PAT: Rs. 522 crore (+9.7% YoY).
EPS for FY26: Rs. 463.66 (basic and diluted).
Outlook and guidance
Management expects continued growth across all business segments, with Health Care leading.
Focus remains on customer engagement and supply chain execution.
Latest events from 3M India
- Q1 FY26 revenue up 19% YoY; PAT surged 31.2% on land sale gain, all segments grew.523395
Q1 26/27 - Double-digit sales growth and industry awards highlight strong innovation and operational excellence.523395Investor presentation
- India sales up 13.6% YTD, fueled by innovation, local R&D, and strategic leadership.523395Investor presentation
- Q3 FY26 saw 12.7% sales growth YoY, but a net loss due to exceptional labor and tax charges.523395Q3 25/26
- Q2 FY26 delivered 14% sales growth and 43% PAT growth YoY, with broad-based segment gains.523395Q2 25/26
- Q1 FY25 profit rose 22% year-over-year on flat revenue, led by Consumer and Safety & Industrial.523395Q1 24/25
- Revenue up 8% YoY, profit and margins down; Health Care leads, cost pressures persist.523395Q3 24/25
- FY25 revenue up 6% with stable EBITDA, but net profit down 18%; Rs. 535/share dividend proposed.523395Q4 24/25
- FY 2024-25 saw 6.1% revenue growth, margin pressure, and a focus on localization and innovation.523395Status Update